Diagnosis of spina bifida on ultrasound: always termination?

Amanda S Trudell, Anthony O Odibo

Journal: Best practice & research. Clinical obstetrics & gynaecology 2014;28(3):367-77

PMID: 24373566

Abstract

Open spina bifida is a non-lethal fetal anomaly. Significant advances in the prevention, diagnosis and treatment of open spina bifida have been made over the past 75 years. The most significant strategy for the prevention of open spina bifida has been with folic acid supplementation; however, further investigation into the complicated role that genetics and the environment play in metabolism are coming to light. Ultrasound is the gold standard diagnostic tool for spina bifida. Three-dimensional ultrasound and magnetic resonance imaging are also beginning to play a role in the characterisation of the open spina bifida spinal lesion. Lesion level has been closely correlated to short and long-term outcomes, and prenatal characterisation of lesion level on ultrasound is important for patient counselling. Long-term outcomes of people living with spina bifida are available and should be used for non-directive patient counselling about pregnancy choices for women with open spina bifida.

Copyright © 2013 Elsevier Ltd. All rights reserved.

Address: Obstetrics and Gynecology, Washington University in St. Louis, 4911 Barnes Jewish Hospital Plaza, Saint Louis, MO 63117, USA. Electronic address: [email protected].; Obstetrics and Gynecology, Washington University in St. Louis, 4911 Barnes Jewish Hospital Plaza, Saint Louis, MO 63117, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.